Advertisement

Topics

Gene Therapy Forms New Polysynaptic Pathways in Parkinson's

14:00 EST 28 Nov 2018 | Drugs.com

WEDNESDAY, Nov. 28, 2018 -- For patients with Parkinson's disease (PD) undergoing gene therapy, new polysynaptic functional pathways develop in the brain, according to a study published in the Nov. 28 issue of Science Translational Medicine. Martin...

Original Article: Gene Therapy Forms New Polysynaptic Pathways in Parkinson's

NEXT ARTICLE

More From BioPortfolio on "Gene Therapy Forms New Polysynaptic Pathways in Parkinson's"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...